Video: Makya- The end-to-end de novo design software from hit discovery to late stage lead optimization

 Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO). It enables design of novel and easy to make compounds in line with multi-objective blueprint with unprecedented speed, performance, and diversity. Watch this video to learn more.